DUBLIN, Oct. 24, 2023 /PRNewswire/ — The “Duchenne Muscular Dystrophy Drugs – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The global market for Duchenne Muscular Dystrophy Drugs, valued at US$2 billion in 2022, is projected to grow to…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.